Azzalure

GPTKB entity

Statements (65)
Predicate Object
gptkbp:instance_of gptkb:botulism
gptkbp:administered_by Healthcare professional
gptkbp:approves gptkb:2010
Medicines and Healthcare products Regulatory Agency (MHRA)
gptkbp:available_in gptkb:Europe
gptkb:United_Kingdom
gptkbp:brand gptkb:Azzalure
gptkbp:clinical_trial Phase 3
Safety and efficacy studies
Comparative studies with other toxins
Long-term effects studies
gptkbp:clinical_use Aesthetic medicine
Therapeutic indications
gptkbp:contraindication Breastfeeding
Pregnancy
Neuromuscular disorders
gptkbp:dosage_form Injection
gptkbp:duration 3 to 6 months
Every 3 to 6 months
gptkbp:formulation Injectable solution
https://www.w3.org/2000/01/rdf-schema#label Azzalure
gptkbp:ingredients Botulinum toxin
gptkbp:invention Patent protected
gptkbp:is_targeted_at Facial muscles
gptkbp:manufacturer gptkb:Ipsen
gptkbp:marketed_as gptkb:Ipsen
gptkbp:mechanism_of_action Inhibits acetylcholine release
gptkbp:packaging Vial
gptkbp:patient_education Expected results explanation
Post-treatment care instructions
Potential side effects information
gptkbp:patient_population gptkb:women
gptkb:Men
Adults
gptkbp:price Varies by provider
Not covered by insurance
gptkbp:provides_guidance_on gptkb:hospital
Follow-up required
Informed consent required
Cosmetic surgery center
Dermatology office
Patient assessment needed
gptkbp:regulatory_compliance Approved
gptkbp:related_to gptkb:Botox
gptkb:Dysport
gptkbp:research_areas Cosmetic dermatology
Aesthetic treatments
Botulinum toxin studies
gptkbp:shelf_life 24 months
gptkbp:side_effect gptkb:Nausea
Allergic reactions
Muscle weakness
Headache
Vision problems
Injection site pain
gptkbp:storage Refrigerated
gptkbp:treatment Patient satisfaction
Improved appearance
Temporary results
gptkbp:used_for Cosmetic treatment
Reduction of wrinkles
gptkbp:website Intramuscular injection
Local anesthesia optional
gptkbp:bfsParent gptkb:Dysport
gptkbp:bfsLayer 7